The STAT3 pathway in myeloid cells is relevant for acquiring immunosuppressive functions [75–77] and for driving the production of cytokines during immune disorders [78], two conditions jointly cooperating to establish a severe lymphopenia, one of the signs of clinical severity in COVID-19 patients. This evidence concerns the gene STAT3 and immune system disorder.